⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ARGX News
argenx SE American Depositary Shares
Unnatural Products Raises $45 Million Series B Financing to Advance Macrocyclic Peptide Therapeutics
globenewswire.com
NVS
MRK
ARGX
Unnatural Products Raises $45 Million Series B Financing to Advance Macrocyclic Peptide Therapeutics
globenewswire.com
NVS
MRK
ARGX
Vyvgart (Argenx) Market Research Report 2026: Epidemiology, Pipeline Analysis, Trends, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F
globenewswire.com
ARGX
Vyvgart (Argenx) Market Research Report 2026: Epidemiology, Pipeline Analysis, Trends, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F
globenewswire.com
ARGX
argenx to Present New Data at 2026 AAN Annual Meeting that Continue to Transform Patient Outcomes in MG and CIDP and Build Upon Strength of Pipeline
globenewswire.com
ARGX
argenx to Present New Data at 2026 AAN Annual Meeting that Continue to Transform Patient Outcomes in MG and CIDP and Build Upon Strength of Pipeline
globenewswire.com
ARGX
Your Kidneys Count: American Kidney Fund Urges Americans to Protect Their Health this Kidney Month
globenewswire.com
AMGN
ARGX
NVS
TVTX
VRTX
genOway: Revolutionizing the Prediction of Antibody Therapies in Humans with Unique Mouse Model USA - English USA - español USA - Français USA - Deutsch Japan - Japanese
prnewswire.com
ARGX
VIR
argenx Reports Full Year 2025 Financial Results and Provides Fourth Quarter Business Update
globenewswire.com
ARGX
argenx Announces Positive Topline Results from Phase 3 ADAPT OCULUS Trial of VYVGART in Ocular Myasthenia Gravis
globenewswire.com
ARGX